Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.

Christian HerderJulia M KannenbergCornelia HuthMaren Carstensen-KirbergWolfgang RathmannWolfgang KoenigAlexander StromGidon J BönhofMargit HeierBarbara ThorandAnnette PetersMichael RodenChrista MeisingerDan Ziegler

Published in: Diabetes/metabolism research and reviews (2018)

Systemic levels of both pro- and antioxidant enzymes appear involved in cardiometabolic risk and development of DSPN.

Keyphrases

risk factors
anti inflammatory
minimally invasive
nitric oxide
drug induced